Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection - Ownership and Business Overview

Life ScienceCompany

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection Ownership

Who owns Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection?

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is owned by Teligent. It was acquired on October 5, 2015.

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection Business Overview

Where is Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection headquartered?

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is headquartered in Oakville, Ontario.

What sector is Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection in?

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is a life science company.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Concordia Pharmaceuticals, Inc. - Frotaz Zinacef ad Zantac Injection

Oakville, Ontario
Canada,

Fortaz®, ZinacefTM, and Zantac® Injection are the products used in specialty generic pharma.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.